Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Prospect Capital Corporation (PSEC) Price & Performance

Eli Lilly And CoTrade
Prospect Capital CorporationTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Prospect Capital Corporation — how do they compare? Eli Lilly And Co trades at $1,214 (market cap $1.08T), while Prospect Capital Corporation trades at $2.29 (market cap $1.14B). The key difference: Eli Lilly And Co is far larger — about 947.4× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (21.93%). Which is the better fit depends on your goals.

LLYPSEC
Market Cap
$1.08T$1.14B
Sector
HealthFinancials
52-Week High
$1.24K$3.05
52-Week Low
$639.43$2.11
Enterprise Value
$1.13T
Dividend Yield
0.57%21.93%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY

About Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

Read more on PSEC